Sera Prognostics, Inc.
General ticker "SERA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $150.7M (TTM average)
Sera Prognostics, Inc. follows the US Stock Market performance with the rate: 0.0%.
Estimated limits based on current volatility of 5.6%: low 2.88$, high 3.22$
Factors to consider:
- Total employees count: 57 (-36.0%) as of 2023
- Top business risk factors: Net losses, Cash dependency, Operational and conduct risks, Customer concentration, Sales/marketing
- Current price 27.8% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [4.13$, 9.35$]
- 2025-12-31 to 2026-12-31 estimated range: [3.46$, 8.01$]
Financial Metrics affecting the SERA estimates:
- Negative: with PPE of -8.3 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -5.19 <= 0.33
- Positive: Investing cash flow per share per price, % of 4.29 > -0.66
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Positive: Industry inventory ratio change (median), % of -0.79 <= -0.15
- Positive: Shareholder equity ratio, % of 65.87 > 63.39
- Positive: Interest expense per share per price, % of 0.01 <= 0.01
Short-term SERA quotes
Long-term SERA plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.27MM | $0.31MM | $0.08MM |
| Operating Expenses | $45.92MM | $40.13MM | $36.71MM |
| Operating Income | $-45.65MM | $-39.82MM | $-36.63MM |
| Non-Operating Income | $1.47MM | $3.58MM | $3.74MM |
| Interest Expense | $0.06MM | $0.06MM | $0.03MM |
| R&D Expense | $14.24MM | $15.22MM | $14.73MM |
| Income(Loss) | $-44.19MM | $-36.24MM | $-32.90MM |
| Profit(Loss)* | $-44.19MM | $-36.24MM | $-32.90MM |
| Stockholders Equity | $98.94MM | $70.16MM | $47.80MM |
| Assets | $116.33MM | $95.44MM | $72.58MM |
| Operating Cash Flow | $-34.61MM | $-27.19MM | $-14.19MM |
| Capital expenditure | $0.79MM | $0.13MM | $1.10MM |
| Investing Cash Flow | $5.55MM | $0.44MM | $11.74MM |
| Financing Cash Flow | $0.01MM | $0.75MM | $2.61MM |
| Earnings Per Share** | $-1.43 | $-1.16 | $-0.99 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.